Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+48Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Prostate Neoplasm+12Malignant Mesothelioma+8Malignant Testicular Neoplasm+8Malignant Anal Neoplasm+4Malignant Kidney Neoplasm+4Malignant Liver Neoplasm+4Malignant Rectal Neoplasm+4Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+48100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21381
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
88
activityPercentile
40

ranking row 2609381

2▲3Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12635
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2609383

2▲2Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3269
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2609382

4▼1Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5598
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2609384

5▲3Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12976
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2609385

5▲10Malignant Pancreatic Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
26605
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
92
activityPercentile
76

ranking row 2609386

5▲2Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
782
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2609387

8▲11Malignant Prostate Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
34815
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2609388

9▲3Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1540
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2609389

9▲1Malignant Testicular Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
462
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
12
activityPercentile
4

ranking row 2609390

11▲6Malignant Anal Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
583
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
24
activityPercentile
20

ranking row 2609393

11▲7Malignant Kidney Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10136
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56

ranking row 2609391

11▲10Malignant Liver Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
19655
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2609392

11▲3Malignant Rectal Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8047
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
56
activityPercentile
52

ranking row 2609394

15▲8Malignant Lung Neoplasm044Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
67037
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2609395

15▲1Malignant Penile Neoplasm044Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
415
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
4
activityPercentile
4

ranking row 2609397

15▲9Malignant Thyroid Gland Neoplasm044Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1048
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2609396

18▲8Leukemia-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13952
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2609398

18▲8Malignant Central Nervous System Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10403
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
64
activityPercentile
72

ranking row 2609399

18▲4Malignant Hypopharyngeal Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
393
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
8

ranking row 2609400

21▲5Malignant Gastric Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6885
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
52
activityPercentile
64

ranking row 2609401

22▲8Hodgkin Lymphoma-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
551
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
20
activityPercentile
36

ranking row 2609402

23▲6Multiple Myeloma-2012Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6423
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
48
activityPercentile
68

ranking row 2609403

24▲7Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11326
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2609404

25▲7Malignant Nasopharyngeal Neoplasm-364Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
459
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
8
activityPercentile
44

ranking row 2609405

26▲10Malignant Breast Neoplasm-800Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
495
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
16
activityPercentile
96

ranking row 2609406

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 0d0aad9990c01ec7597b7feb